Thursday, February 4, 2010

Medical News

Medical News


Atorvastatin cuts CHD risk in stroke patients

Posted: 04 Feb 2010 04:00 PM PST

Further results from the SPARCL trial show that stroke patients given atorvastatin have a reduced risk for coronary heart disease events, as well as recurrent stroke.

Increased risk for depression in COPD patients confirmed

Posted: 04 Feb 2010 04:00 PM PST

Patients with chronic obstructive pulmonary disease (COPD) face a significantly increased risk for depression, study results confirm.

Exposure to air pollution linked to asthma risk in childhood

Posted: 04 Feb 2010 04:00 PM PST

Increased exposure to air pollution in utero and during the first year of life is associated with an increased risk for childhood asthma, research shows.

Inhaled steroids ‘of limited benefit’ in preventing COPD exacerbations

Posted: 04 Feb 2010 04:00 PM PST

Inhaled corticosteroids (ICSs) have only modest benefits for the prevention of exacerbations in chronic obstructive pulmonary disease (COPD) patients, results from a systematic review show.

Schizophrenia relapse is costly and predicts subsequent relapse

Posted: 04 Feb 2010 04:00 PM PST

Researchers have found that relapse of schizophrenia is associated with substantial healthcare costs and remains an important predictor of subsequent relapse.

Cortisol levels persistently elevated in offspring of parents with bipolar disorder

Posted: 04 Feb 2010 04:00 PM PST

Children born to parents with bipiolar disorder appear to have increased cortisol levels that persist over time, say researchers.

Breast reduction does not interfere with screening mammography

Posted: 04 Feb 2010 04:00 PM PST

Postoperative breast changes following reduction mammoplasty do not hinder analysis of the screening mammogram, Australian researchers report.

Quitting smoking reduces heart disease risk despite weight gain

Posted: 04 Feb 2010 04:00 PM PST

Stopping smoking can lead to weight gain and a worsening in some cardiovascular risk factors, Japanese research suggests, but it still markedly reduces an individual's estimated risk of coronary heart disease.

Addition of omega-3 fatty acids to atorvastatin improves lipid levels

Posted: 04 Feb 2010 04:00 PM PST

Taking prescription omega-3-acid ethyl esters plus atorvastatin improves lipid levels to a significantly greater extent than atorvastatin plus placebo, report researchers.

Anticarbohydrate antibodies, gASCA distinguish IBD from non-IBD patients

Posted: 04 Feb 2010 04:00 PM PST

Study findings suggest that inflammatory bowel disease patients can be distinguished from non-IBD patients using a panel of anticarbohydrate antibodies and simultaneous detection of anti-Saccharomyces cerevisiae antibodies.

Atorvastatin cuts CHD risk in stroke patients

Posted: 04 Feb 2010 04:00 PM PST

Further results from the SPARCL trial show that stroke patients given atorvastatin have a reduced risk for coronary heart disease events, as well as recurrent stroke.

Breast reduction does not interfere with screening mammography

Posted: 04 Feb 2010 04:00 PM PST

Postoperative breast changes following reduction mammoplasty do not hinder analysis of the screening mammogram, Australian researchers report.

Maintaining remifentanil infusion benefits recovery

Posted: 04 Feb 2010 04:00 PM PST

Maintaining a remifentanil infusion during the emergence and tracheal extubation minimizes cardiovascular changes and coughing in patients after total intravenous anesthesia, without delaying recovery, researchers report.

Bilateral TKA associated with poor peri-operative outcome

Posted: 04 Feb 2010 04:00 PM PST

Unilateral total knee arthroplasty appears to be associated with better peri-operative morbidity and mortality than bilateral procedures, say researchers.

Atomized lidocaine 1% inferior to 2% for airway anesthesia

Posted: 04 Feb 2010 04:00 PM PST

Atomized lidocaine 2% is effective for awake oral fiberoptic intubation in morbidly obese patients and provides superior intubating conditions to lidocaine 1%, say Canadian researchers.

Benefits of aprotonin outweigh risks in high-risk cardiac surgery patients

Posted: 04 Feb 2010 04:00 PM PST

Aprotonin for preventing major blood loss after cardiac surgery has a better risk–benefit profile than tranexamic acid in high-risk, but not low-to-moderate risk patients, study findings show.

Single negative compression ultrasound may rule out DVT

Posted: 03 Feb 2010 04:00 PM PST

A single negative compression ultrasound result may be sufficent for ruling out deep vein thrombosis and withholding anticoagulation therapy in some patients, suggest the results of a meta-analysis.

Prostate cancer susceptibility genes influenced by ethnicity

Posted: 03 Feb 2010 04:00 PM PST

US research findings confirm the involvement of ELAC2, MSR1, and RNASEL genes in the risk for development of prostate cancer, and show that the risk varies according to ethnicity.

One in eight undergoing repeated PSA screening receive false-positive result

Posted: 03 Feb 2010 04:00 PM PST

Every eighth man undergoing repeated prostate-specific antigen screening will have at least one false-positive result, show findings from the Finnish component of the European Randomized Study of Screening for Prostate Cancer.

Letrozole plus bevacizumab ‘feasible’ for metastatic breast cancer

Posted: 03 Feb 2010 04:00 PM PST

Treatment with the aromatase inhibitior letrozole plus the anti-vascular endothelial growth factor antibody bevacizumab is feasible in postmenopausal patients with hormone receptor-positive metastatic breast cancer, US research shows.

Prostate cancer susceptibility genes influenced by ethnicity

Posted: 03 Feb 2010 04:00 PM PST

US research findings confirm the involvement of ELAC2, MSR1, and RNASEL genes in the risk for development of prostate cancer, and show that the risk varies according to ethnicity.

One in eight undergoing repeated PSA screening receive false-positive result

Posted: 03 Feb 2010 04:00 PM PST

Every eighth man undergoing repeated prostate-specific antigen screening will have at least one false-positive result, show findings from the Finnish component of the European Randomized Study of Screening for Prostate Cancer.

Micro- and macrovascular dysfunction evident with the metabolic syndrome

Posted: 03 Feb 2010 04:00 PM PST

People with the metabolic syndrome display both micro- and macrovascular dysfunction even if they have neither diabetes nor cardiovascular disease, researchers have shown.

Lifestyle intervention program improves global CV risk profile

Posted: 03 Feb 2010 04:00 PM PST

A structured comprehensive lifestyle intervention program is effective for improving anthropometric and lipid measures in overweight patients with hypercholesterolemia, research suggests.

Benefits of periodontal treatment for Type 2 diabetics confirmed

Posted: 03 Feb 2010 04:00 PM PST

Results from a systematic review and meta-analysis confirm previous results showing that treatment of periodontitis results in improved glycemic control for Type 2 diabetes patients.

Positive impact of exenatide on BP, weight ‘warrants further study’

Posted: 03 Feb 2010 04:00 PM PST

The diabetes drug exenatide is associated with reductions in systolic blood pressure (BP) and body weight, a randomized clinical trial has found.

Achieving Healthy People 2010 targets ‘could halve US CHD deaths’

Posted: 03 Feb 2010 04:00 PM PST

Achieving the Healthy People 2010 cardiovascular risk factor targets would have almost halved the number of predicted coronary heart disease deaths in 2010 in the USA, report researchers.

AHA issues advisory on potential CV risk of common prostate cancer therapy

Posted: 03 Feb 2010 04:00 PM PST

A joint Scientific Advisory from the American Heart Association, American Cancer Society, and American Urological Association advises physicians about the potential risk for cardiovascular disease (CVD) associated with androgen deprivation therapy (ADT), a widely used treatment for prostate cancer.

Letrozole plus bevacizumab ‘feasible’ for metastatic breast cancer

Posted: 03 Feb 2010 04:00 PM PST

Treatment with the aromatase inhibitior letrozole plus the anti-vascular endothelial growth factor antibody bevacizumab is feasible in postmenopausal patients with hormone receptor-positive metastatic breast cancer, US research shows.

Robotic RP associated with low numbers of peri-operative complications

Posted: 02 Feb 2010 04:00 PM PST

Prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy experience low rates of peri-operative complications, even when the procedure is carried out by surgeons new to the technique, report researchers.

Regular screening improves breast cancer life expectancy

Posted: 02 Feb 2010 04:00 PM PST

Women with small sized invasive screen-detected breast cancer have the same life expectancy as the general population, a long-term follow-up study in The Netherlands reveals.

FPMs raise biochemical recurrence risk even in organ-confined prostate cancer

Posted: 01 Feb 2010 04:00 PM PST

The presence of focal positive margins after prostate cancer surgery increase a man's risk for biochemical disease recurrence, even if his cancer is organ-confined, report researchers.

Prostate cancer diagnosis increases immediate risk for suicide and cardiovascular death

Posted: 01 Feb 2010 04:00 PM PST

A prostate cancer diagnosis increases a man's risk for suicide and cardiovascular death in the months immediately following diagnosis, according to study results.

<i>ER</i> polymorphisms not linked to tamoxifen-associated BMD change

Posted: 01 Feb 2010 04:00 PM PST

An evaluation of single nucleotide polymorphisms in the estrogen receptor and cytochrome P450 2D6 genes has found no link with a change in bone mineral density during tamoxifen therapy.

Prostate biopsy DNA content predicts need for treatment

Posted: 31 Jan 2010 04:00 PM PST

Certain DNA content measurements found in the diagnostic biopsies of prostate cancer patients can indicate subsequent conversion to an unfavorable biopsy necessitating the need for treatment, study findings show.

Acupuncture shows promise for vasomotor symptoms in breast cancer

Posted: 31 Jan 2010 04:00 PM PST

Acupuncture is as effective as venlafaxine in decreasing the number of hot flashes in women treated with hormone therapy for breast cancer, US researchers report.

No comments:

Post a Comment